RÉSUMÉ
Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis. Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1ß but not tumour-necrosis factor-α in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and downregulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1ß as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1ß production during inflammation.
Sujet(s)
Sous-unité alpha du facteur-1 induit par l'hypoxie/métabolisme , Interleukine-1 bêta/biosynthèse , Transduction du signal , Acide succinique/métabolisme , Animaux , Cellules de la moelle osseuse/cytologie , Cycle citrique/effets des médicaments et des substances chimiques , Désoxyglucose/pharmacologie , Régulation négative/effets des médicaments et des substances chimiques , Gènes de mitochondrie/effets des médicaments et des substances chimiques , Gènes de mitochondrie/génétique , Glutamine/métabolisme , Glycolyse/effets des médicaments et des substances chimiques , Glycolyse/génétique , Humains , Immunité innée/effets des médicaments et des substances chimiques , Inflammation/métabolisme , Interleukine-1 bêta/génétique , Lipopolysaccharides/pharmacologie , Macrophages/cytologie , Macrophages/effets des médicaments et des substances chimiques , Macrophages/métabolisme , Souris , Régulation positive/effets des médicaments et des substances chimiques , Acide gamma-amino-butyrique/métabolismeRÉSUMÉ
In recent years, studies have demonstrated an association between human cytomegalovirus (HCMV) and destructive periodontal disease. It has been shown that reactivation of HCMV in periodontitis lesions may be related to progressing periodontal disease. Several possible mechanisms by which HCMV exerts periodontopathic potential have been previously proposed. These are reviewed and include the upregulation of bone resorptive cytokines such as interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) by active HCMV infection at the periodontitis site. This review focuses on the molecular basis of IL-1beta gene activation by HCMV immediate early (IE) gene products. A novel hypothesis is also described whereby HCMV plays a significant role in the pathogenesis of periodontal disease by the ability of its IE proteins to strongly transactivate IL-1beta gene expression. More studies are needed to further explore this hypothesis and clarify the association between HCMV and periodontitis.
Sujet(s)
Cytomegalovirus/génétique , Régulation de l'expression des gènes viraux/génétique , Interleukine-1/génétique , Parodontite/virologie , Transcription génétique/génétique , Résorption osseuse/immunologie , Évolution de la maladie , Humains , Protéines précoces immédiates/génétique , Interleukine-1/immunologie , Parodontite/immunologie , Activation de la transcription/génétique , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/immunologie , Régulation positive/génétique , Activation virale/physiologieRÉSUMÉ
Both cell-specific and ubiquitous transcription factors in fibroblasts have been identified as critical for expression of the Col1a1 gene, which encodes the alpha1 chain of type I collagen. Here, we report that Yin Yang 1 (YY1) binds to the Col1a1 promoter immediately upstream of the TATA box, and we examine the functional implications of YY1 binding for regulation of Col1a1 gene expression in BALBc/3T3 fibroblasts. The Col1a1 promoter region spanning base pairs (bp) -56 to -9 bound purified recombinant YY1 and the corresponding binding activity in nuclear extracts was supershifted using a YY1-specific antibody. Mutation of the TATA box to TgTA enhanced YY1 complex formation. Mutation analysis revealed two YY1 core binding sites at -40/-37 bp (YY1A) and, on the reverse strand, at -32/-29 bp (YY1B) immediately adjacent to the TATA box. In transfections using Col1a1-luciferase constructs, mutation of YY1A decreased activity completely (wild-type p350 (p350wt), -222/+113 bp) or partially (p130wt, -84 bp/+13 bp), whereas mutation of YY1B blocked the expression of both promoter constructs. Cotransfection with pCMV-YY1 increased p350wt and p130wt activities by as much as 10-fold, whereas antisense YY1 decreased constitutive expression and blocked the increased activity due to pCMV-YY1 overexpression. The mTgTA constructs were devoid of activity, arguing for a requirement for cognate binding of the TATA box-binding protein (TBP). Electrophoretic mobility shift assays performed under conditions permitting TBP binding showed that recombinant TBP/TFIID and YY1 could bind to the -56/-9 bp fragment and that YY1B was the preferred site for YY1 binding. Our results indicate that YY1 binds to the Col1a1 proximal promoter and functions as a positive regulator of constitutive activity in fibroblasts. Although YY1 is not sufficient for transcriptional initiation, it is a required component of the transcription machinery in this promoter.
Sujet(s)
Collagène de type I , Collagène/génétique , Collagène/métabolisme , Protéines de liaison à l'ADN/métabolisme , Régulation de l'expression des gènes , Facteurs de transcription/métabolisme , Transcription génétique , Cellules 3T3 , Animaux , Séquence nucléotidique , Sites de fixation , Noyau de la cellule/métabolisme , Chaine alpha-1 du collagène de type I , Analyse de mutations d'ADN , Facteurs érythroïdes spécifiques , Luciferases/métabolisme , Souris , Données de séquences moléculaires , Mutation , Oligonucléotides antisens/pharmacologie , Régions promotrices (génétique) , Liaison aux protéines , Facteur de transcription TFIID , Facteurs de transcription TFII/métabolisme , Transfection , Facteur de transcription YY1RÉSUMÉ
This review examines a well-characterized factor, interleukin 1 (IL-1), that has recently received considerable attention. A level of understanding is emerging that goes beyond simple recognition that IL-1 plays a role in disease, and begins to explain the molecular mechanisms of function. This review summarizes some current information on the importance of IL-1 in periodontitis as well as the signal transduction of IL-1, from binding to its cell-surface receptors, to the activation of cytoplasmic mediators and transcription factors responsible for the induction of target genes. The effect of IL-1 signal transduction is ultimately the activation and repression of specific transcription factors that regulate genes responsible for cellular activities. As additional steps of signal transduction become better-characterized, these insights may facilitate the development of improved therapeutic approaches for controlling inflammation and connective tissue destruction in a variety of diseases.
Sujet(s)
Protéines de Drosophila , Interleukine-1/physiologie , Parodontite/métabolisme , Récepteurs immunologiques , Transduction du signal/physiologie , Protéines adaptatrices de la transduction du signal , Animaux , Antigènes de différenciation/métabolisme , Humains , Interleukine-1/génétique , Interleukin-1 Receptor-Associated Kinases , Glycoprotéines membranaires/métabolisme , Facteur de différenciation myéloïde-88 , Parodontite/génétique , Polymorphisme génétique , Protein kinases/métabolisme , Protéines/métabolisme , Récepteurs de surface cellulaire/métabolisme , Récepteurs à l'interleukine-1/métabolisme , Facteur-6 associé aux récepteurs de TNF , Récepteurs de type Toll , Activation de la transcriptionRÉSUMÉ
The contribution of osteoclasts to the process of bone loss in inflammatory arthritis has recently been demonstrated. Studies in osteoclast biology have led to the identification of factors responsible for the differentiation and activation of osteoclasts, the most important of which is the receptor activator of NF-kappa B ligand/osteoclast differentiation factor (RANKL/ODF), a tumor necrosis factor (TNF)-like protein. The RANKL/ODF receptor, receptor activator of NF-kappa B (RANK), is a TNF-receptor family member present on both osteoclast precursors and mature osteoclasts. Like other TNF-family receptors and the IL-1 receptor, RANK mediates its signal transduction via TNF receptor-associated factor (TRAF) proteins, suggesting that the signaling pathways activated by RANK and other inflammatory cytokines involved in osteoclast differentiation and activation are interconnected.
Sujet(s)
Résorption osseuse/métabolisme , Protéines de transport/physiologie , Glycoprotéines/physiologie , Glycoprotéines membranaires/physiologie , Protéines/physiologie , Récepteurs cytoplasmiques et nucléaires/physiologie , Récepteurs aux facteurs de nécrose tumorale/physiologie , Animaux , Résorption osseuse/anatomopathologie , Différenciation cellulaire , Humains , Ostéoprotégérine , Ligand de RANK , Récepteur activateur du facteur nucléaire Kappa B , Transduction du signal , Facteur-1 associé aux récepteurs de TNF , Facteur-2 associé aux récepteurs de TNF , Facteur-3 associé aux récepteurs de TNF , Facteur-4 associé aux récepteurs de TNF , Facteur-5 associé aux récepteurs de TNF , Facteur-6 associé aux récepteurs de TNF , Protéines et peptides associés aux récepteurs des facteurs de nécrose tumoraleRÉSUMÉ
Two classes of transcription factors, ETS and bZIP, stand out as key mediators of monocyte commitment and differentiation. The ETS domain factor Spi-1 (also called PU.1) and the bZIP factor NF-IL6 (also called C/EBPbeta) have been shown to be involved in the transcriptional regulation of interleukin-1beta gene (il1b) and other monocyte-specific genes. We now show that these two factors strongly cooperate on the il1b core promoter (-59/+12) in the absence of direct NF-IL6 binding to DNA. Transient transfection assays, using mutated il1b core promoters, showed that the Spi-1, but not the NF-IL6, binding site is absolutely required for functional cooperativity. Furthermore, the NF-IL6 transactivation domain (TAD) is functionally indispensable and more critical than that of Spi-1. Additionally, TAD-deficient NF-IL6 functions as a dominant negative for Spi-1-mediated activation, suggesting the involvement of the bZIP DNA binding domain. This is supported by the demonstration of in vitro interaction between the NF-IL6 bZIP and Spi-1 winged helix-turn-helix (wHTH) DNA binding domains, arguing that NF-IL6 vigorously activates the il1b core promoter via protein-tethered transactivation mediated by Spi-1.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Régulation de l'expression des gènes/immunologie , Interleukine-1/génétique , Protéines nucléaires/métabolisme , Régions promotrices (génétique) , Protéines proto-oncogènes/métabolisme , Transactivateurs/métabolisme , Séquence nucléotidique , Sites de fixation , Protéines liant les séquences stimulatrices de type CCAAT , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Cellules HeLa , Humains , Lipopolysaccharides/pharmacologie , Liaison aux protéines , Protéines recombinantes/métabolisme , 12-Myristate-13-acétate de phorbol/pharmacologie , Facteurs de transcription/métabolisme , TransfectionRÉSUMÉ
The activation status of a recently identified STAT (signal transducers and activators of transcription) factor, LIL-Stat (lipopolysaccharide [LPS]/IL-1-inducible Stat) in adult T-cell leukemia (ATL) cells was investigated by electrophoretic mobility shift assays using nuclear extracts of leukemic cells from 7 patients with ATL and a GAS (gamma interferon activation site)-like element termed LILRE (LPS/IL-1-responsive element), which is found in the human prointerleukin 1beta (IL1B) gene. Spontaneous DNA binding of LIL-Stat was observed in all ATL cells examined. However, in normal human peripheral lymphocytes, DNA binding of LIL-Stat was detected only after stimulation with IL-1. These results demonstrated that LIL-Stat is constitutively activated in ATL cells. Furthermore, our transient transfection studies using LILRE chloramphenicol acetyltransferase (CAT) reporters argue that LIL-Stat in ATL cells functions as a transcriptional activator through binding to the LILRE in the IL1B gene. (Blood. 2000;95:2715-2718)
Sujet(s)
Régulation de l'expression des gènes tumoraux , Leucémie à cellules T/génétique , Facteurs de transcription/génétique , Maladie aigüe , Adulte , Humains , Leucémie à cellules T/métabolisme , Transduction du signal/génétique , Facteurs de transcription/métabolismeRÉSUMÉ
Potent induction of the gene coding for human prointerleukin 1beta (il1b) normally requires a far-upstream inducible enhancer in addition to a minimal promoter located between positions -131 and +12. The transcription factor Spi-1 (also called PU.1) is necessary for expression and binds to the minimal promoter, thus providing an essential transcription activation domain (TAD). In contrast, infection by human cytomegalovirus (HCMV) can strongly activate il1b via the expression of immediate early (IE) viral proteins and eliminates the requirement for the upstream enhancer. Spi-1 has been circumstantially implicated as a host factor in this process. We report here the molecular basis for the direct involvement of Spi-1 in HCMV activation of il1b. Transfection of Spi-1-deficient HeLa cells demonstrated both the requirement of Spi-1 for IE activity and the need for a shorter promoter (-59 to +12) than that required in the absence of IE proteins. Furthermore, in contrast to normal, enhancer-dependent il1b expression, which absolutely requires both the Spi-1 winged helix-turn-helix (wHTH) DNA-binding domain and the majority of the Spi-1 TAD, il1b expression in the presence of IE proteins does not require the Spi-1 TAD, which plays a synergistic role. In addition, we demonstrate that a single IE protein, IE2, is critical for the induction of il1b. Protein-protein interaction experiments revealed that the wing motif within the Spi-1 wHTH domain directly recruits IE2. In turn, IE2 physically associates with the Spi-1 wing and requires the integrity of at least one region of IE2. Functional analysis demonstrates that both this region and a carboxy-terminal acidic TAD are required for IE2 function. Therefore, we propose a protein-tethered transactivation mechanism in which the il1b promoter-bound Spi-1 wHTH tethers IE2, which provides a TAD, resulting in the transactivation of il1b.
Sujet(s)
Protéines précoces immédiates/métabolisme , Interleukine-1/génétique , Glycoprotéines membranaires , Protéines proto-oncogènes/métabolisme , Transactivateurs/métabolisme , Activation de la transcription , Protéines de l'enveloppe virale , Protéines virales , Sites de fixation , Protéines de liaison à l'ADN/métabolisme , Éléments activateurs (génétique) , Cellules HeLa , Motifs à hélice-boucle-hélice , Humains , Protéines précoces immédiates/génétique , Modèles génétiques , Régions promotrices (génétique) , Liaison aux protéines , Structure secondaire des protéines , Protéines proto-oncogènes/déficit , Protéines proto-oncogènes/génétique , Transactivateurs/déficit , Transactivateurs/génétiqueRÉSUMÉ
The process through which multipotential hematopoietic cells commit to distinct lineages involves the induction of specific transcription factors. PU.1 (also known as Spi-1) and GATA-1 are transcription factors essential for the development of myeloid and erythroid lineages, respectively. Overexpression of PU.1 and GATA-1 can block differentiation in lineages in which they normally are down-regulated, indicating that not only positive but negative regulation of these factors plays a role in normal hematopoietic lineage development. Here we demonstrate that a region of the PU.1 Ets domain (the winged helix-turn-helix wing) interacts with the conserved carboxyl-terminal zinc finger of GATA-1 and GATA-2 and that GATA proteins inhibit PU.1 transactivation of critical myeloid target genes. We demonstrate further that GATA inhibits binding of PU.1 to c-Jun, a critical coactivator of PU.1 transactivation of myeloid promoters. Finally, PU.1 protein can inhibit both GATA-1 and GATA-2 transactivation function. Our results suggest that interactions between PU.1 and GATA proteins play a critical role in the decision of stem cells to commit to erythroid vs. myeloid lineages.
Sujet(s)
Protéines de liaison à l'ADN/génétique , Hématopoïèse/génétique , Protéines proto-oncogènes/génétique , Protéines de répression/génétique , Transactivateurs/génétique , Facteurs de transcription/génétique , Animaux , Différenciation cellulaire , Lignée cellulaire , Chlorocebus aethiops , Protéines de liaison à l'ADN/métabolisme , Facteurs érythroïdes spécifiques , Facteur de transcription GATA-1 , Facteur de transcription GATA-2 , Régulation de l'expression des gènes , Humains , Tests aux précipitines , Liaison aux protéines , Protéines proto-oncogènes/métabolisme , Protéines proto-oncogènes c-jun/métabolisme , Protéines de fusion recombinantes/métabolisme , Protéines de répression/métabolisme , Transactivateurs/métabolisme , Facteurs de transcription/métabolisme , Activation de la transcription , Transfection , Levures/génétique , Doigts de zinc/génétiqueRÉSUMÉ
Interleukin 1 (IL-1) delivers a stimulatory signal which increases the expression of a set of genes by modulating the transcription factor NF-kappaB. The IL-1 receptors are transmembrane glycoproteins which lack a catalytic domain. The C-terminal portion of the type I IL-1 receptor (IL-IRI) is essential for IL-1 signalling and for IL-1 dependent activation of NF-kappaB. This portion contains a putative phosphatidylinositol 3-kinase (PI 3-kinase) binding domain (Tyr-E-X-Met), which is highly conserved between the human, mouse and chicken sequences, as well as the related cytoplasmic domain of the Drosophila receptor Toll. This observation prompted us to investigate the role of PI 3-kinase in IL-1 signalling. Here we report evidence that PI 3-kinase is recruited by the activated IL-IRI, causing rapid and transient activation of PI 3-kinase. We also show that the receptor is tyrosine phosphorylated in response to IL-1. Expression of a receptor mutant lacking the putative binding site for p85 demonstrates that Tyr479 in the receptor cytoplasmic domain is essential for PI 3-kinase activation by IL-1. Our results indicate that PI 3-kinase is likely to be an important mediator of some IL-1 effects, providing docking sites for additional signalling molecules.
Sujet(s)
Interleukine-1/pharmacologie , Phosphatidylinositol 3-kinases/métabolisme , Récepteurs à l'interleukine-1/métabolisme , Sites de fixation , Séquence consensus , Activation enzymatique , Humains , Interleukine-1/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Ostéosarcome , Phosphorylation , Phosphotyrosine/métabolisme , Tests aux précipitines , Liaison aux protéines , Récepteurs à l'interleukine-1/composition chimique , Récepteur à l'interleukine-1 de type I , Activation de la transcription , Transfection , Cellules cancéreuses en culture , Tyrosine/métabolisme , Domaine d'homologie SRC/physiologieRÉSUMÉ
The interleukin 1 (IL-1) receptor is a critical component in mediating the inflammatory responses of IL-1, which affect nearly every cell type. Recently, major inroads have been made toward understanding the mechanism by which IL-1 interacts with its receptor and activates signal transduction. The receptor-ligand association has been visualized by X-ray crystal structure analysis, revealing intimate details that distinguish IL-1beta from the naturally-occuring receptor antagonist. Signaling studies have focused primarily on the ability of IL-1 to transduce the activation of the transcription factor, NF-kappaB, which is of central importance to inflammatory and immune responses. Virtually all of the effort has targeted the activation of a kinase which results in the phosphorylation of the inhibitory IkappaB molecule at two serines that precedes the proteolytic degradation of this inhibitor and the release of active NF-kappaB. The recent characterization of an IL-1 receptor associated kinase (IRAK) and a continuous molecular path between this kinase and that which directly phosphorylates IkappaB would seem to all but close the basic understanding of IL-1 receptor signal transduction. However, at least half of the IL-1-dependent NF-kappaB activation is independent of IRAK and uses a novel pathway involving the recruitment of phosphatidylinositol 3-kinase (PI3K) to a distinct site within the cytoplasmic domain of the IL-1 receptor. This novel pathway for NF-kappaB activation and the fact that other important transcription factors are also activated by an IL-1 receptor-dependent signal event, clearly defines additional mechanisms that influence inflammation.
Sujet(s)
Récepteurs à l'interleukine-1/physiologie , Transduction du signal/immunologie , Animaux , Humains , Ligands , Modèles moléculaires , Liaison aux protéines/immunologie , Récepteurs à l'interleukine-1/métabolismeRÉSUMÉ
Heat shock factor 1, the critical molecular regulator of the stress response is conserved throughout eukaryotic organisms and activates the transcription of heat shock genes. We now show that heat shock factor 1 inhibits the expression of c-fos, an immediate early gene that controls responses to extracellular stimuli for growth and differentiation. Heat shock factor 1 inhibits the transcription of the c-fos gene and antagonizes the activating effects of the signal transducing protein Ras on the c-fos promoter and on the promoter of another Ras responsive gene uPA. This property was specific for heat shock factor 1; c-fos repression was not seen with the structurally related protein heat shock factor 2. Repression involved different molecular mechanisms compared with those involved in transcriptional activation by heat shock factor 1 and specifically did not require binding to the c-fos promoter. Thus, in addition to its known role as a transcriptional activator of the cellular heat shock response, heat shock factor 1 also antagonizes the expression of Fos, a key component of the ubiquitous AP-1 transcription factor complex and as such could influence multiple aspects of cell regulation.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Gènes fos , Protéines proto-oncogènes c-fos/biosynthèse , Protéines proto-oncogènes p21(ras)/métabolisme , Facteurs de transcription/métabolisme , Transcription génétique , Animaux , Cellules CHO , Cricetinae , Protéines de liaison à l'ADN/biosynthèse , Gènes rapporteurs , Facteurs de transcription de choc thermique , Protéines du choc thermique/biosynthèse , Protéines du choc thermique/métabolisme , Humains , Luciferases/biosynthèse , Régions promotrices (génétique) , Protéines proto-oncogènes p21(ras)/biosynthèse , Protéines de fusion recombinantes/biosynthèse , Facteurs de transcription/biosynthèse , Transfection , Activateur du plasminogène de type urokinase/biosynthèse , beta-Galactosidase/biosynthèseRÉSUMÉ
The human T-cell leukemia virus type I (HTLV-I), which infects a wide variety of mammalian cells including monocytes and macrophages, encodes a transactivating protein designated as Tax. We now report that Tax induces the human prointerleukin-1beta (IL1B) gene promoter in monocytic cells. In our transient transfection assays using human THP-1 monocytic cells, a chloramphenicol acetyltransferase (CAT) construct containing the IL1B promoter sequence between positions -131 and +12 showed an approximately 90-fold increase in activity following cotransfection of a Tax expression vector. Moreover, Tax synergized with lipopolysaccharide (LPS) to induce the IL1B promoter activity. Analyses of specific nucleotide substitutions further indicated that the Tax-induced transcriptional activation requires two transcription factor binding motifs within the IL1B promoter; one is a binding site for nuclear factor (NF)-IL6 (CCAAT/enhancer binding protein beta, C/EBP beta), which belongs to the basic region-leucine zipper (bZIP) family and the other for Spi-1 (PU.1), which is an Ets family protein found principally in monocytes, macrophages, and B lymphocytes. In electrophoretic mobility shift assays (EMSA) using in vivo THP-1 nuclear extracts, Tax expression in THP-1 monocytic cells significantly increased binding of the two factors to their target IL1B promoter sequences. However, in contrast to NF-IL6 and Spi-1, DNA binding activity of Oct-1, an ubiquitously expressed octamer-binding protein was not affected by Tax. Additional EMSA using in vitro translated proteins also showed that recombinant Tax enhances DNA binding of both of recombinant NF-IL6 and Spi-1 proteins. These data were supported by our glutathione S-transferase (GST)-pull-down data, which indicated that Tax physically interacts with the two proteins. Based on the results obtained from the present study, we conclude that the IL1B promoter is a Tax-responsive sequence as a result of ability of Tax to induce binding of NF-IL6 and Spi-1 to the IL1B promoter sequence through protein-protein interaction.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Produits du gène tax/métabolisme , Virus T-lymphotrope humain de type 1 , Interleukine-1/génétique , Protéines nucléaires/métabolisme , Régions promotrices (génétique) , Précurseurs de protéines/génétique , Protéines proto-oncogènes/métabolisme , Transactivateurs/métabolisme , Facteurs de transcription/métabolisme , Activation de la transcription , Sites de fixation , Protéines liant les séquences stimulatrices de type CCAAT , Cellules cultivées , ADN/métabolisme , Facteur de prolifération cellulaire HCF , Humains , Facteur de transcription Oct-1 , Liaison aux protéinesRÉSUMÉ
Leukocytes adhere to target cells through their integrins and play a crucial role in self-defense, inflammation, and differentiation. Intercellular adhesion molecule-1 (ICAM-1; CD54) is a representative ligand for integrins and is expressed on many cell types, some of which are targets for leukocyte adhesion. Recent studies suggest that adhesion molecules function not only as a cellular glue, but also as a signal transducer. However, it remains to be clearly defined whether engagement of ICAM-1 is able to induce activation signals in target cells. In rheumatoid synovium, synovial cells are known to express abundant ICAM-1 and produce multiple inflammatory cytokines, such as IL-1beta. In this study, we provide the first evidence that ICAM-1 engagement induces activation of the transcription factor AP-1 and transcription of the IL-1beta gene using a specific Ab to cross-link ICAM-1 on a rheumatoid synovial cell line (E11 cells). This evidence includes ICAM-1 cross-linking-dependent induction of 1) in situ IL-1beta transcription and protein synthesis, 2) transiently transfected chloramphenicol acetyltransferase (CAT) reporter plasmids containing both the IL-1beta LPS-responsive enhancer (between -3134 and -2729) as well as multiple copies of an AP-1 site from this enhancer (between -3117 and -3111), and 3) the binding of a Jun/Fos family complex to this AP-1 site. Thus, ICAM-1 not only functions as a glue for integrin binding, but also as a transducer for AP-1 activation signals important for IL-1beta gene transcription.
Sujet(s)
Molécule-1 d'adhérence intercellulaire/métabolisme , Interleukine-1/génétique , Facteur de transcription AP-1/métabolisme , Animaux , Anticorps monoclonaux , Séquence nucléotidique , Sites de fixation , Lignée cellulaire , Chloramphenicol O-acetyltransferase/génétique , Réactifs réticulants , ADN/génétique , ADN/métabolisme , Amorces ADN/génétique , Éléments activateurs (génétique)/effets des médicaments et des substances chimiques , Humains , Molécule-1 d'adhérence intercellulaire/composition chimique , Lipopolysaccharides/pharmacologie , Souris , Plasmides/génétique , Récepteurs du fragment Fc des IgG/métabolisme , Transduction du signal , Transcription génétique , TransfectionRÉSUMÉ
Heat shock factor 1 activates the promoters of heat shock genes at elevated temperatures through its interaction with heat shock elements. We have examined a new role for heat shock factor 1 in the repression of the prointerleukin 1beta gene in human monocytes responding to stimulation with lipopolysaccharide. Both exposure to elevated temperatures and heat-independent heat shock factor 1 expression repressed the transcription of the prointerleukin 1beta gene, and repression was strictly dependent on an intact consensus heat shock element in the prointerleukin 1beta promoter to which heat shock factor 1 bound. This is the first demonstration of heat shock factor 1 as a transcriptional repressor and suggests a role for the factor in the counter-regulation of cytokine gene transcription.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Interleukine-1/génétique , Précurseurs de protéines/génétique , Protéines de répression/métabolisme , Transcription génétique , Cellules 3T3 , Animaux , Séquence nucléotidique , Lignée cellulaire , Séquence consensus , ADN , Protéines de liaison à l'ADN/génétique , Facteurs de transcription de choc thermique , Humains , Souris , Données de séquences moléculaires , Mutagenèse , Régions promotrices (génétique) , Liaison aux protéines , Facteurs de transcriptionRÉSUMÉ
Binding of many cytokines to their cognate receptors immediately activates Jak tyrosine kinases and their substrates, STAT (signal transducers and activators of transcription) DNA-binding proteins. The DNA binding targets of STATs are sequence elements related to the archetypal gamma interferon activation site, GAS. However, association of interleukin 1 (IL-1) with Jak-STAT signaling has remained unresolved. We now report an element termed LILRE (lipopolysaccharide [LPS] and IL-1-responsive element) in the human prointerleukin 1beta gene (IL1B) which can be immediately induced by either lipopolysaccharide (LPS) or IL-1 protein to bind a tyrosine-phosphorylated protein. This LPS- and IL-1-induced factor (LIL factor) is recognized by an antibody raised against the N terminus of Stat1, but not by those specific for either the C terminus of Stat1 or any other GAS-binding STAT. Phosphotyrosine (P-Tyr) specifically inhibits formation of the LIL factor-DNA complex, suggesting the importance of P-Tyr for the DNA-binding activity, as has been found for all STAT dimers. Analysis of DNA-binding specificity demonstrates that the LIL factor possesses a novel GAS-like binding activity that contrasts with those of other STATs in a requirement for a G residue at position 8 (TTCCTGAGA). Further investigation has revealed that IL-6, but neither IL-4 nor gamma interferon, activates the LIL factor. Thus, the existence of such a STAT-like factor (LIL-Stat) relates the LPS and IL-1 signaling pathway to other cytokine receptor signaling pathways via the activation of STATs. Moreover, the unique DNA-binding specificity and antigenicity of this factor suggest that LPS, IL-1, and IL-6 may use a common signaling pathway.
Sujet(s)
Protéines de liaison à l'ADN/métabolisme , Interféron gamma/métabolisme , Interleukine-1/génétique , Interleukine-1/pharmacologie , Interleukine-6/pharmacologie , Lipopolysaccharides/pharmacologie , Transduction du signal , Facteurs de transcription/métabolisme , Activation de la transcription , Séquence d'acides aminés , Animaux , Anticorps , Séquence nucléotidique , Sites de fixation , Lignée cellulaire , Noyau de la cellule/métabolisme , Protéines de liaison à l'ADN/isolement et purification , Expression des gènes/effets des médicaments et des substances chimiques , Humains , Souris , Données de séquences moléculaires , Oligodésoxyribonucléotides , Phosphopeptides/synthèse chimique , Phosphopeptides/composition chimique , Phosphoprotéines/composition chimique , Phosphoprotéines/métabolisme , Phosphotyrosine , Protéines recombinantes/pharmacologie , Similitude de séquences d'acides nucléiques , Thymome , Tumeurs du thymus , Facteurs de transcription/isolement et purification , Cellules cancéreuses en cultureRÉSUMÉ
n-3 Polyunsaturated fatty acids abundant in marine lipids suppress certain inflammatory and immune reactions, and dietary marine lipid supplements have antiinflammatory effects in experimental and human autoimmune disease. Previous work by other investigators demonstrated that dietary marine lipid supplements suppressed production of cytokines from stimulated human peripheral blood mononuclear cells ex vivo. The present study further documents the ability of n-3 fatty acids to inhibit cytokine formation, and in part defines the mechanism of the inhibition of production of interleukin-1 beta (IL-1 beta) by dietary n-3 fatty acid. Female BALB/c mice were each fed a fat-free balanced diet to which was added either a refined fish oil (FO) preparation as a source of n-3 fatty acid, or beef tallow (BT), which consisted primarily of saturated and monoenoic fatty acids. After ingesting the experimental diets for periods ranging from 3 to 12 wk. spleen cell preparations were stimulated ex vivo with either lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA), and proIL-1 beta mRNA (IL-1 beta mRNA) was measured by northern analysis. Levels of IL-1 beta mRNA in both LPS- and PMA-stimulated cells from BT-fed mice were elevated to a greater extent than in cells from FO-fed mice, at most concentrations of LPS and PMA. Stability of LPS-stimulated mRNA levels after actinomycin D was similar for BT and FO groups, indicating that lower levels of IL-1 mRNA with FO groups was related to suppressed IL-1 gene transcription and not due to accelerated transcript degradation. Nuclear run-on transcription assays revealed a more transient expression of the IL-1 beta gene in LPS-stimulated spleen cells from FO-fed mice compared to cells from BT-fed mice. We conclude that dietary marine lipids reduce transient expression of the IL-1 beta gene in stimulated splenic monocytic cells. Preliminary results from nuclear run-on transcription assays indicate that n-3 fatty acids may not change the initial rate of gene transcription but may promote more rapid shutting down of transcription of this gene after induction than do alternative lipids.
Sujet(s)
Matières grasses alimentaires/pharmacologie , Acides gras omega-3/pharmacologie , Interleukine-1/génétique , ARN messager/métabolisme , Rate/métabolisme , Transcription génétique , Animaux , Femelle , Lipopolysaccharides/pharmacologie , Souris , Souris de lignée BALB C , Phospholipides/métabolisme , Rate/cytologie , 12-Myristate-13-acétate de phorbol/pharmacologieRÉSUMÉ
Further functional and biochemical characterization of the nuclear factor(s) which interacts with the EOS1 enhancer-like element in the IL-5R alpha promoter is currently in progress. Since different transcription factors recognize and interact with DNA in distinct fashions and with distinct structural motifs, we have modeled potential binding of the EOS1 factor to its cis-element based upon its methylation interference pattern (Fig. 2), using a cylindrical DNA helical projection (Fig. 6). Over a length of two helical turns, all nuclear protein contacts indicated by methylation interference map to one side of the DNA helix, suggesting that EOS1 binds in the major groove, across the minor groove, and on only one side of the helix. Further review of the model also reveals a potential diad symmetry for the binding site, suggestive of binding by a homodimer and consistent with the formation of the two DNA-protein complexes in our electrophoretic mobility shift experiments that could represent interactions with monomer versus dimer. Comparison of the EOS1 binding motif to similar models for the binding of other transcription factor families for which structural crystallographic and/or binding data is available suggests a similarity of the EOS1 complex to that of the bacterial helix-turn-helix phage lambda and 434 repressor-operator complexes, and the Cys4 zinc finger glucocorticoid response element (GRE) DNA-binding motifs, all of which show similar diad symmetry and binding in the major groove on one side of the DNA. The possibility that EOS1 functions as a GRE is being investigated, especially since there is a consensus AP-1 site at bp -440 to -432 of the IL-5R alpha promoter, immediately adjacent to the EOS1 binding site (see Fig. 5 in reference [36]) and AP-1/GRE interactions have been identified for composite response elements in the regulation of a number of different genes. The identification or cloning of EOS1, a potentially novel and eosinophil lineage-active transcription factor, should enhance our understanding of the processes involved in eosinophil development in particular and myeloid lineage commitment and differentiation in general.
Sujet(s)
Éléments activateurs (génétique) , Granulocytes éosinophiles/physiologie , Régulation de l'expression des gènes , Hématopoïèse/génétique , Régions promotrices (génétique) , Récepteurs aux interleukines/génétique , Animaux , Séquence nucléotidique , Humains , Données de séquences moléculaires , Récepteurs à l'interleukine-5RÉSUMÉ
Interleukin-1 beta (IL-1 beta) is produced primarily by stimulated monocytes, suggesting that the IL1B gene, which codes for this protein, depends upon at least one cell-type-specific factor. Our previous characterization of the IL1B promoter indicated that the region between -131 and +12 is sufficient to direct cell-type-specific expression of a reporter gene (F. Shirakawa, K. Saito, C.A. Bonagura, D.L. Galson, M.J. Fenton, A.C. Webb, and P. E. Auron, Mol. Cell. Biol. 13:1332-1344, 1993). We now show that a sequence located between positions -50 and -39 of the IL1B promoter binds the tissue-restricted Ets domain transcription factor Spi-1/PU.1 (Spi-1). Mutation of this site abrogates binding of this factor and reduces the ability of the IL1B promoter to function in macrophages. A second Spi-1 binding site located between positions -115 and -97 also is required for maximal IL1B promoter activity in the presence of the proximal Spi-1 binding site. In addition, an activation domain-deficient Spi-1 expression vector acts as a dominant-negative inhibitor of reporter gene expression in a monocyte cell line. Finally, the IL1B promoter, which is inactive in Spi-1-deficient HeLa cells, is activated in these cells by cotransfection with a Spi-1 expression vector. Thus, the cell-type-specific expression of the IL1B promoter appears to be dependent on the binding of Spi-1.